177 related articles for article (PubMed ID: 33530992)
1. Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attack.
Ma TT; Wong ICK; Whittlesea C; Man KKC; Lau W; Wang Z; Brauer R; MacDonald TM; Mackenzie IS; Wei L
BMC Med; 2021 Feb; 19(1):24. PubMed ID: 33530992
[TBL] [Abstract][Full Text] [Related]
2. Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II?
Hwong WY; Bots ML; Selvarajah S; Abdul Aziz Z; Sidek NN; Spiering W; Kappelle LJ; Vaartjes I
PLoS One; 2016; 11(11):e0166524. PubMed ID: 27846309
[TBL] [Abstract][Full Text] [Related]
3. Diuretics versus others for long-term clinical outcomes as first-line antihypertensive medications: analysis of national real-world database.
Kim HL; Hwang D; Lee JH; Lee HY; Ihm SH; Kim KI; Shin J; Park S; Kim DH; Sung KC
Hypertens Res; 2022 May; 45(5):758-768. PubMed ID: 35338336
[TBL] [Abstract][Full Text] [Related]
4. Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke.
Zeng Y; Nie K; Wallace KL; Li F; Zhang J; Li C; Wang Y; Zhang J; Wang J; Jiang C
Oxid Med Cell Longev; 2023; 2023():7733857. PubMed ID: 36778208
[TBL] [Abstract][Full Text] [Related]
5. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
[TBL] [Abstract][Full Text] [Related]
6. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Martin N; Manoharan K; Davies C; Lumbers RT
Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072
[TBL] [Abstract][Full Text] [Related]
7. Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.
Driscoll A; Currey J; Tonkin A; Krum H
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009889. PubMed ID: 26689943
[TBL] [Abstract][Full Text] [Related]
8. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
Zhao HJ; Li Y; Liu SM; Sun XG; Li M; Hao Y; Cui LQ; Wang AH
Ren Fail; 2016 Jul; 38(6):849-56. PubMed ID: 27055479
[TBL] [Abstract][Full Text] [Related]
9. Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke.
Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Angelopoulou SM; Margariti E; Savopoulos C; Hatzitolios AI
Clin Exp Hypertens; 2017; 39(3):246-250. PubMed ID: 28448189
[TBL] [Abstract][Full Text] [Related]
10. Deintensification or No Statin Treatment Is Associated With Higher Mortality in Patients With Ischemic Stroke or Transient Ischemic Attack.
Dearborn-Tomazos JL; Hu X; Bravata DM; Phadke MA; Baye FM; Myers LJ; Concato J; Zillich AJ; Reeves MJ; Sico JJ
Stroke; 2021 Aug; 52(8):2521-2529. PubMed ID: 34015937
[TBL] [Abstract][Full Text] [Related]
11. Greater Adherence to Secondary Prevention Medications Improves Survival After Stroke or Transient Ischemic Attack: A Linked Registry Study.
Dalli LL; Kim J; Cadilhac DA; Greenland M; Sanfilippo FM; Andrew NE; Thrift AG; Grimley R; Lindley RI; Sundararajan V; Crompton DE; Lannin NA; Anderson CS; Whiley L; Kilkenny MF
Stroke; 2021 Nov; 52(11):3569-3577. PubMed ID: 34315251
[TBL] [Abstract][Full Text] [Related]
12. The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis.
Pongpanich P; Pitakpaiboonkul P; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
Int Urol Nephrol; 2018 Dec; 50(12):2261-2278. PubMed ID: 30324578
[TBL] [Abstract][Full Text] [Related]
13. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
Lee J; Lee S
Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
[TBL] [Abstract][Full Text] [Related]
15. Comparative risk of new-onset diabetes mellitus for antihypertensive drugs in elderly: A Bayesian network meta-analysis.
Zhang J; Tong A; Dai Y; Niu J; Yu F; Xu F
J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1082-1090. PubMed ID: 31241860
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blockers versus other classes of drugs for hypertension.
Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD003654. PubMed ID: 35000192
[TBL] [Abstract][Full Text] [Related]
18. Calcium channel blockers versus other classes of drugs for hypertension.
Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003654. PubMed ID: 34657281
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Jeffers BW; Robbins J; Bhambri R
Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.
Marott SC; Nielsen SF; Benn M; Nordestgaard BG
Eur Heart J; 2014 May; 35(18):1205-14. PubMed ID: 24347316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
